CASE REPORT
Published on 06 Nov 2025
Combination therapy with toripalimab and lenvatinib in metastatic type 2 papillary renal cell carcinoma: a Case Report
doi 10.3389/fimmu.2025.1591489
- 462 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Biomarker Discovery and Therapeutic Innovations in Genito-Urinary Cancer Management
Biomarker Discovery and Therapeutic Innovations in Genito-Urinary Cancer Management
8,542
Total downloads
36k
Total views and downloads
Articles
ORIGINAL RESEARCH
Accepted on 28 Oct 2025
Evaluation of Expression Profiles of APOA4, CEACAM1, CD147, DJ-1/PARK7, Gamma-synuclein, S100A1, and Stathmin-1 in Urothelial Carcinomas using Immunohistochemical Assays
- 140 views
SYSTEMATIC REVIEW
Published on 03 Oct 2025
Prognostic value of lymphocyte to monocyte ratio for the patients with bladder cancer: a systematic review and meta-analysis
doi 10.3389/fonc.2025.1601040
- 890 views
ORIGINAL RESEARCH
Published on 11 Sep 2025
Multi-omics dissection of fatty acid metabolism heterogeneity identifies PRDX1 as a prognostic marker in bladder cancer
doi 10.3389/fimmu.2025.1669822
- 1,230 views
ORIGINAL RESEARCH
Published on 10 Sep 2025
Prognostic value and molecular mechanism of photodynamic therapy and apoptosis related gene FGFR1 in bladder cancer
doi 10.3389/fonc.2025.1578695
- 1,098 views
CASE REPORT
Published on 05 Sep 2025
Case Report: The first account of primary myeloid sarcoma of the testis combined with ipsilateral epididymal epithelioid hemangioendothelioma
doi 10.3389/fmed.2025.1590907
- 1,157 views
ORIGINAL RESEARCH
Published on 29 Aug 2025
Angiogenesis-related gene NID2 profiling and immune infiltration in bladder cancer: prognostic implications and immunotherapy response
doi 10.3389/fimmu.2025.1615173
- 1,299 views
ORIGINAL RESEARCH
Published on 17 Jul 2025
PCP4 inhibits the progression of prostate cancer through Ca2+/CAMKK2/AMPK/AR pathway
doi 10.3389/fimmu.2025.1616046
- 1,291 views
ORIGINAL RESEARCH
Published on 15 Jul 2025
Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancer
doi 10.3389/fimmu.2025.1585727
- 3,882 views
CASE REPORT
Published on 02 May 2025
Case Report: Clinical response of ensartinib for inflammatory myofibroblastic tumor of the urinary bladder with multiple metastases and TPM4-ALK fusion
doi 10.3389/fonc.2025.1481602
- 1,117 views
SYSTEMATIC REVIEW
Published on 17 Mar 2025
Prognostic and predictive value of pre-treatment blood-based inflammatory biomarkers in patients with urothelial carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1554048
- 2,308 views
MINI REVIEW
Published on 15 Jan 2025
Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy
doi 10.3389/fonc.2024.1457006
- 2,286 views
- 4 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore